- Investing Ideas
- /
- French Pharmaceuticals & Biotech Financially Fit Penny Stocks
French Pharmaceuticals & Biotech Financially Fit Penny Stocks
Results
5
0 new
A Penny Stocks screener, typically smaller or younger companies trading at a price below 5, with a focus on solid financial health that should present companies with a lower risk profile than other early-stage businesses
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AELIS | €2.88 | -2.0% | -78.5% | €39.2m | €14.20 | PS3.6x | E33.8% | n/a | ||
ABNX | €1.22 | -7.9% | -6.0% | €42.3m | €11.50 | PS8.7x | E-23.4% | n/a | ||
ALVAL | €1.23 | -1.1% | -78.0% | €19.5m | €6.35 | PS36.9x | E59.3% | n/a | ||
ALGEN | €3.76 | 0.8% | -11.3% | €33.9m | n/a | PE27x | n/a | n/a | ||
IPH | €1.53 | 2.0% | -33.0% | €124.0m | €6.25 | PS3.7x | E36.6% | n/a |
Page 1 of 1